2004
DOI: 10.1016/j.transproceed.2004.08.071
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic factors affecting graft and patient survival in cadaveric and living kidney transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
5
0
10

Year Published

2005
2005
2013
2013

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 7 publications
2
5
0
10
Order By: Relevance
“…In our multivariate analysis of all patients, LD recipients continued to have a survival advantage over the referent DD group, except in the oldest LD category where the results were not significantly different. As expected, both short-and long-term graft survivals for recipients of a younger LD kidney (age [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34] was significantly better than the ideal DD. Interestingly, an advantage was also seen for children who received kidneys from LD aged 50-54 yr of age.…”
Section: Resultssupporting
confidence: 56%
See 2 more Smart Citations
“…In our multivariate analysis of all patients, LD recipients continued to have a survival advantage over the referent DD group, except in the oldest LD category where the results were not significantly different. As expected, both short-and long-term graft survivals for recipients of a younger LD kidney (age [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34] was significantly better than the ideal DD. Interestingly, an advantage was also seen for children who received kidneys from LD aged 50-54 yr of age.…”
Section: Resultssupporting
confidence: 56%
“…The one‐yr allograft survival in pediatric recipients for LD and DD in the 1995–2004 North American Pediatric Renal Trials and Collaborative Studies cohorts was reported as 96% and 93%, while the seven‐yr survival was 76% and 65%, respectively. Therefore, recipients of LD transplants appear to have longer short‐ and long‐term allograft survival overall (1–3, 6, 7, 12, 14–26).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…There has been some controversial discussion regarding the best reconstruction method for evaluating CT data in the setting of donor work‐up [22]. For arterial assessment we preferred to view CT images first with a scroll modus in axial and coronal reconstructions (slice thickness, 1 mm).…”
Section: Discussionmentioning
confidence: 99%
“…Já a transfusão de CH, foi forte fator de risco independente de mortalidade, fato concordante com outros estudos realizados em TH adulto92,146 e pediátrico173,174 .A sobrevida global dos pacientes ao longo de 1 ano, 5 anos e 10 anos pó-TH foi, respectivamente, de 87,1%; 81,5% e 80,3% e a sobrevida global dos enxertos foi, respectivamente, de 87,1%; 77,7% e 75,6%, valores compatíveis com resultados obtidos em outros grandes centros33,37 . A análise comparativa entre as curvas de sobrevida de pacientes e enxertos, demonstrou uma menor sobrevida de ambos ao longo de 1, 5 e 10 anos no grupo ACH, em comparação ao grupo BCH, confirmando relatos prévios de que a transfusão de CH aumenta o número de complicações pós-operatórias, bem como, abrevia a sobrevida de pacientes e enxertos92,93,146,147,175 .…”
unclassified